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Overview
In 2010, the Registry and Surveillance System for 
Hemoglobinopathies (RuSH) pilot project was implemented by 
the Centers for Disease Control and Prevention (CDC) to collect 
state-specific, population-based data on people with sickle 
cell disease (SCD) and thalassemia. The pilot project is being 
supported and conducted in collaboration with the National 
Institutes of Health’s National Heart, Lung, and Blood Institute. 
Overall project goals include determining the number of 
people who have SCD and thalassemia and increasing 
knowledge and awareness about health care use and 
outcomes. Currently, seven states are funded to participate 
in data collection: California, Florida, Georgia, Michigan, New 
York, North Carolina, and Pennsylvania. In addition to collecting 
and linking their unique data to help reach these goals, the 
states also have planned and implemented health promotion 
initiatives designed to increase awareness about RuSH in the 
affected communities to aid in the data collection
It is anticipated that these state-based surveillance data will:
 y Provide estimates of the number of new cases (incidence) of 
SCD and thalassemia each year. 
 y Provide estimates of the total number of existing cases 
(prevalence) of SCD and thalassemia.
 y Provide information on trends in medical care for people 
with these disorders.
 y Provide information about complications and death rates.
 y Provide information to assist with planning public health 
interventions (i.e., services, health promotion campaigns, 
health education, and training) to improve the health of 
these populations.

8RuSH—Strategies from the Field: Health Promotion
Strategy Field Reports
The purpose of this document is to showcase some of the 
unique ways in which the states have implemented activities 
designed to meet the programmatic goals of RuSH. In the 
following sections, each state highlights one of their many 
programs and features information about the resources 
needed to operate or replicate the activity, as well as intended 
benefits and outcomes, and provides a set of lessons learned 
to readers.  Intended aims of this document are the provision 
of contact and programmatic information to other entities for 
the potential modification or replication, or both, of activities.  
Additionally, this document can be used to inform and 
motivate appropriate community members in the creation of 
a supportive environment for the RuSH program to assist the 
program in moving forward. 
The information in this report was provided by programmatic 
team members who worked with CDC staff in fall 2011. This 
document comprises the following RuSH health promotion 
strategies from the field:
 y Putting the Focus on Sickle Cell:  Northern California’s Focus 
Group and Stakeholder Meetings
 y Resource STREET: Sickle Cell Disease and Thalassemia 
Resources To Educate and Empower the Community  An 
Online Database Serving Southern California
 y Connecting the Dots:  Building a Provider Network and 
Directory in Florida
 y Finding Our Voice:  Creating and Implementing a 
Community Speaker Panel in Georgia
 y Measuring Michigan’s Health:  A Hemoglobinopathy Health 
Status Assessment 
 y Garnering Statewide Support for RuSH: Regional Provider 
Meetings in New York
 y Faith-based Initiative: North Carolina’s Approach to 
Community Outreach for Hemoglobinopathies
 y Answering the Call:  Pennsylvania’s Toll-Free Telephone 
Number for Hemoglobinopathy Health Care Referrals
The RuSH program will conclude in September 2012. 
Development of a strategies document highlighting 
surveillance activities conducted by the participating states is in 
progress.
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Putting the Focus on Sickle Cell:  
Northern California’s Focus Group and  
Stakeholder Meetings
Program Overview
Individuals with hemoglobinopathies, specifically sickle 
cell disease (SCD) and thalassemia, face significant barriers 
accessing health care services and participating in public 
health and clinical research projects. These barriers are related, 
in part, to the cultural and linguistic diversity within the 
affected populations and mistrust between clients or patients 
and providers, as well as social and economic barriers. These 
barriers call attention to the need for increased sensitivity 
and communication surrounding the initiation of new studies 
and projects that might offend or stigmatize the targeted 
population. To address these issues, the Northern California 
RuSH education and outreach team designed focus groups 
and stakeholder meetings to address the effects of RuSH 
on the SCD and thalassemia communities. The primary 
objective was to obtain input from stakeholders through 
focus groups  on how to (1) engage the SCD and thalassemia 
communities with the RuSH project, (2) address potential 
barriers to hemoglobinopathies surveillance, (3) assess the 
appropriateness and appeal of the RuSH messaging tools, and 
(4) identify additional community stakeholders who should be 
engaged with the RuSH project.
Resources Needed
Qualitative data and clinical research expertise was used to 
help design a script for the focus groups that addressed the 
objectives. A standard definition of the terms “surveillance” and 
“registry”, and examples of each, was presented to the groups. 
Established community connections were used to compile 
the invitations for initial focus group meetings. To solicit 
participation in future focus groups, stakeholders were asked to 
identify additional community contacts.
A convenient and comfortable meeting space was reserved 
to host the focus group meetings. The meeting environment 
limited external distractions, and food was provided before the 
sessions began. The group facilitator led the discussions  
with a note-taker present, and each session was recorded  
using a digital recording device. The notes were reconciled with 
the recording transcripts immediately following the  
focus group meetings.
Benefits
Information gathered from the stakeholder focus group 
meetings is intended to provide guidance to the RuSH project 
about potential barriers and perceived benefits to surveillance 
and participation in a registry program. Feedback from 
stakeholders has been valuable in the design, marketing, and 
implementation of the RuSH project. The focus groups have 
allowed the RuSH project team to foster a relationship with 
affected communities, thereby influencing subsequent actions 
to be transparent and consumer focused. Another benefit of 
the focus groups is the opportunity to provide basic education 
about hemoglobinopathies to communities that might or 
might not be affected directly by the diseases or complications, 
but would benefit from targeted education.
Outcomes
To date, four focus groups of stakeholders have been 
convened, with a total of 34 individuals participating. 
Participants included the psychosocial team members of 
a comprehensive sickle cell center, leadership of regional 
SCD community-based organizations, individuals with 
thalassemia, and staff from the local Asian Health Services 
program. Participants were educated briefly about public 
health surveillance and asked to respond to questions about 
barriers to and facilitators of community participation in 
surveillance for hemoglobinopathies. Participants reviewed 
and critiqued written materials created for RuSH and identified 
other important groups to target, to share RuSH messaging. 
11
Registry and Surveillance System for Hemoglobinopathies
Following the focus group meetings, Northern California 
RuSH team members reviewed notes and audio transcripts 
independently to identify common themes within and  
across groups. 
The focus groups identified common themes around 
surveillance, which included concerns about who will have 
access to the data and what will be done with it, and the need 
to identify and communicate direct benefits to patients. Focus 
group members saw RuSH as a means of educating providers 
and the general community about hemoglobinopathies and 
suggested customizing materials (culture and language) for 
different audiences (e.g., providers, patients, communities). 
Perhaps the most valuable feedback identified the potential 
barriers to surveillance and registry data collection. Historic 
mistrust among targeted groups and cultural mores 
maintaining secrecy about the conditions were cited as  
major factors. Participants also provided a diverse listing of 
regional community health, provider, faith-based, social, and 
academic groups that should be approached as potential 
supporters of RuSH.
Lessons Learned
 y 15 minutes should be allotted for general education on 
hemoglobinopathies at the beginning of the focus groups, 
especially for groups that are further removed from health 
care fields, such as cultural organizations, sororities, and 
fraternities. 
 y Educational  materials should be clear about the potential 
effects of the RuSH project on research and health practice, 
as well as specific actions the community can take to 
support the RuSH project.
 y Educational materials should be customized for  
diverse audiences, which includes taking into account 
various language and cultural differences, audiences  
and age groups.
Next Steps
The Northern California RuSH education and outreach 
committee continues to contact groups identified through prior 
focus groups to organize new focus groups, specifically with 
patients with SCD and local community SCD and thalassemia 
provider groups. Focus group results were summarized in an 
abstract, with plans to publish the data. 
Contact Information
Lisa Feuchtbaum, Dr.P.H., M.P.H. 
California Department of Public Health 
E-mail Address: Lisa.Feuchtbaum@cdph.ca.gov 
Phone: (510) 412-1455 
CA RuSH Website: www.casicklecell.org 
Words from the Field
“What is going to be the benefit of participating in 
surveillance? Better access to care? Now, that’s a true 
incentive!” 
— Sickle Cell CBO Leader 
“I hope that a program like [RuSH] will put more 
pressure on providers to follow the standards of care 
for thalassemia.” 
— Thalassemia Patient
“Having [a] record of cases and information about 
patients will show policymakers how many people are 
living with thalassemia and sickle cell in this country; 
real numbers. Right now, it’s vague; they think it’s 
really rare. Hopefully, this will make it easier for them 
to see what their constituents look like.” 
— Thalassemia Patient
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Resource STREET:  
Sickle Cell Disease and Thalassemia Resources to 
Educate and Empower the Community —  
An Online Database Serving Southern California
Program Overview
Resource STREET is a comprehensive, online database that 
manages information relevant to the community outreach 
elements of the California RuSH project. In an effort to reach out 
to specific communities affected by sickle cell disease (SCD) and 
thalassemia, the database was created to capture and organize 
available resources. The database contains information about 
individuals active in sickle cell and thalassemia communities, 
community organizations, institutions, and other entities 
offering direct or support services to patients and their families; 
it does not contain patient information.
The database provides a central resource for RuSH staff 
in Southern California, as well as for community-based 
organizations that are participating in the project. There are 
over 18,000 providers and 4,000 organizations and institutions 
in the database. 
The flexibility of the database allows for several things:
 y Users can update information in real time. 
 y People or organizations can be grouped together and 
marked as public or private.
 y Detailed information about an organization, such as mission 
statement, programs, languages supported, and a link to the 
organization’s homepage can be entered.
 y Information can be shown on a map (locations of providers, 
organizations, and other resources). 
 y Customized reports can be generated.
 y The database allows for queries concerning usage, such as 
the volume of activity using each outreach method.
Resources Needed
The fundamental computer code developed for the database 
is available to anyone interested in building a database with 
similar components. A fundamental license for Microsoft SQL 
Server® 2008 is required. Installation and setup of the database 
requires assistance from the developer. Fees for developer 
services have to be arranged through individual contracts, 
and there might be fees associated with hosting the database 
locally or through a common provider such as Amazon.com®.
It is important to have one or two individuals who are 
knowledgeable about the system and able to answer questions 
for other users designated as data managers. The data 
managers ensure the accuracy and integrity of the information 
and oversee data input and output. 
Benefits
There are significant benefits to having information in one 
place, immediately accessible to users, and flexible so that users 
can enter the information and create personalized groups. A 
relational database provides the ability to retrieve information 
in a wide variety of ways, such as:
 y Providing a common repository for all contact information 
for individuals or organizations whose services might be of 
use to providers or patients with thalassemia or SCD.
 y Providing the information in a normalized relational 
database format such that queries and reports can be 
generated.
 y Allowing geographic localization of resources, including 
medical providers.
 y Allowing tracking of the effectiveness of various resources 
and assisting hemoglobinopathy programs and patients.
By providing a central repository and allowing individuals to 
contribute to the database over time, the total amount of work 
and time spent in locating resources throughout the state can 
be reduced.
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Outcomes
The database has been invaluable for generating mailing lists 
to send outreach materials, surveys, and other information to 
target groups of providers and organizations. The Southern 
California RuSH team has also been able to connect patients 
with resources available in their geographic area. A newly 
created community based organization in Southern California 
has expressed an interest in obtaining access to the database 
and using it for project management. There are plans to 
survey users for feedback on ease of use and functionality, and 
suggestions for improvement.
Lessons Learned
Database development is a trial and error process, and it 
is difficult to anticipate exactly how long each stage of 
development will take. Plenty of time should be allowed to 
design and redesign elements of the database, as well as for 
users to adapt to the new system and receive assistance. It is 
helpful to have personnel on call to field questions as they arise.
Next Steps
This database serves as a common repository of information to 
identify providers, agencies, and individuals with resources for 
SCD and thalassemia. Eventual implementation of a geographic 
mapping module will allow patients and providers to identify 
resources within a defined geographic area.
Use of this program with community-based organizations in 
California will continue.  Key staff members have been trained 
to update the database on a regular basis, and there are plans 
to continue maintaining the system.
Contact Information
Lisa Feuchtbaum, Dr.P.H., M.P.H. 
California Department of Public Health 
E-mail Address: Lisa.Feuchtbaum@cdph.ca.gov 
Phone: (510) 412-1455 
CA RuSH Website: www.casicklecell.org 
Words from the Field
“Our Southern California sickle cell community 
needed a database to manage information about 
resources, and we’re glad this project happened. 
We can share the information with people who 
are looking for resources and those new to our SC 
Community. As a sickle cell educator and health 
advocate, the database has allowed me to focus my 
time on other important issues for our community.” 
— N.T.
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Connecting the Dots:  
Building a Provider Network and Directory in Florida
Program Overview
The Florida RuSH coalition formed three advisory committees, 
one of which is the Community Partnership and Health 
Education Committee, consisting of leaders from sickle 
cell community-based organizations (CBO) and state-
funded sickle cell outreach coordinators. The Community 
Partnership and Health Education Committee discussed the 
need for a provider directory that would serve as a referral 
resource of hemoglobinopathy experts who provide care, 
care coordination, counseling, education, and follow-up for 
individuals with a hemoglobinopathy (sickle cell disease [SCD] 
or thalassemia). 
An initial task in creating such a directory was obtaining the 
location of hemoglobinopathy physicians and other providers 
and hospitals in Florida, in addition to other pertinent 
information. The South Broward Hospital District (SBHD) 
Planning and Marketing Department obtained SCD- and 
thalassemia-specific data from the Agency for Healthcare 
Administration (AHCA), for fiscal year 2008. AHCA is the state 
agency that collects data on hospital and emergency room 
discharges, surgery, and ambulatory care centers. Information 
from AHCA was divided into the following categories: pediatric, 
adult, inpatient, outpatient, emergency room utilization, and 
physician. Data were assembled based on information from 
top volume hospitals and physicians and other providers into 
a Microsoft® Excel file. The directory then was shared with the 
Community Partnership and Health Education Committee and 
Florida’s Children’s Medical Services (CMS) hematology and 
oncology centers. 
Resources Needed
To replicate a state- or geographic-specific physician and other 
provider directory, access to  the state’s health care inpatient, 
outpatient, ambulatory, emergency room, and hospital 
discharge data is necessary, as well as provider’s disease- 
specific volume data. Minimal staff is needed to create and 
maintain the directory. 
Benefits
The purpose of the physician and provider directory is to assist 
SCD and thalassemia patients, community-based organizations, 
outreach educators, and anyone in need of locating a 
hematologist with expertise in SCD and thalassemia. Thus, 
benefits include increased referrals for services and support, 
closing the gap between patients and services, and access to 
a more comprehensive care system for hemoglobinopathy 
patients and their families.
Outcomes
A notable outcome is the use of the tool by Florida CMS nurses 
whose role is to provide care coordination (case management) 
for CMS-eligible children from birth through 21 years of age. 
CMS is a Title V program that provides care for children with 
special health care needs through 22 CMS area offices. CMS 
nurses have reported that this directory has assisted them in 
finding adult providers for adolescent patients. 
Anticipated Outcomes: 
 y Assists individuals with hemoglobinopathies in locating 
expert providers within or close to their community. 
 y Assists CMS area offices in connecting patients 18 through 
21 years of age with local adult physicians and other 
providers. 
 y Creates a network of physicians and other providers in the 
state of Florida with expertise in hemoglobinopathies.
 y Identifies gaps in geographic distribution of physicians and 
other providers with hemoglobinopathy expertise.
 y Identifies gaps in service location.
 y Monitors hemoglobinopathy health care usage trends.
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Lessons Learned
An important lesson learned from the development and 
dissemination of the physician directory is that there is a greater 
need for such a resource than initially projected. Although the 
Florida RuSH coalition generated the physician directory, it 
was not immediately shared with the Community Partnership 
and Health Education Committee because the coalition 
was unaware of the immediate need in the sickle cell and 
thalassemia communities. Communication across workgroups 
and committee is a valuable tool that can create pathways from 
resources to those who need them most. 
Next Steps
The next step will be the creation of a map of Florida 
highlighting geographic locations of physicians and other 
providers who treat hemoglobinopathies. Currently, Florida 
is reaching out to physicians and other providers to provide 
hemoglobinopathy patient data through a secure website, 
as part of the data collection activities for the RuSH initiative. 
When physicians and other providers sign up for the online 
data collection account, they will be prompted to indicate if 
their practice or services may be included on the map and in 
the directory. The option to be included in the mapping system 
and directory also will be offered to any other physicians or 
providers. All physicians and providers who are interested in 
this system will be verified using the Florida Department of 
Health Provider Search website. 
Contact Information
Mary Beth Vickers, RN, MSN 
Florida Department of Health 
Marybeth_vickers@doh.state.fl.us 
(850) 245-4222  
FL RuSH Website: http://www.cms-kids.com 
Words from the Field
“One of the biggest challenges faced by patients and 
families is to identify a hematologist. The physician 
and other provider directory will assist sickle cell 
disease and thalassemia patients, community- based 
organizations, outreach educators, and anyone else 
in need of locating a hematologist with expertise in 
sickle cell disease and thalassemia.” 
— Lanetta Jordan, MD, MPH, MSPH, 
Director, Sickle Cell Services, 
Memorial Healthcare System, Florida
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Finding Our Voice:  
Creating and Implementing a  
Community Speaker Panel in Georgia
Program Overview
The Sickle Cell Foundation of Georgia (SCFG) has a long history 
of providing outreach and education to sickle cell clients 
throughout the state. To extend and guide outreach efforts, the 
SCFG and its partners created a speaker panel to promote the 
RuSH project to sickle cell disease (SCD) clients, the community, 
and health care providers. Five key strategies were used to 
create and initiate the speaker panel and will be used in the 
near future to train the speakers: (1) carefully select speaker 
panel representatives, (2) focus on creating messaging relevant 
to key audiences, (3) design materials for Spanish-speaking 
audiences, (4) use a highly regarded training curriculum, and (5) 
activate health care provider connections to reach additional 
key audiences.
Resources Needed
A variety of resources are used to implement five key strategies. 
Strategy #1: Carefully select speaker panel representatives
 y Data from the RuSH project is used to identify counties with 
high concentrations of individuals with SCD and racial and 
ethnic groups of interest.
 y Sickle cell support groups are used to identify contacts in 
counties of interest.
 y Existing and newly established relationships with 
support group leaders are utilized; leaders with a strong 
commitment to education and outreach are identified as 
potential panel speakers.
 y A wide range of representatives are selected to ensure a 
variety of resources will be available.
Strategy #2: Focus on messaging relevant to key audiences
 y A deep knowledge of SCD clients and their needs and 
interests helps formulate messaging.
Strategy #3: Design materials for Spanish-speaking audiences
 y Staff that specialize in outreach for this audience are 
engaged to generate materials.  
Strategy #4: Use a highly regarded training curriculum
 y The Baby STEP® curriculum, created by health care 
specialists from the University of Alabama, Birmingham, is 
distributed to all speaker panelists for use in presentations.
Strategy #5: Activate health care provider connections to 
reach additional key audiences 
 y Relationships with health care providers specializing in the 
treatment of SCD are employed to facilitate connections 
with other health care providers.
Benefits
Carefully selecting  panel members who are also support 
group leaders and crafting messages relevant to their client 
audiences strengthens the connection between the RuSH 
project outreach activities and the ultimate goal of improving 
outcomes for clients. Designing materials for Spanish-speaking 
audiences helps the speaker panel overcome language barriers. 
People often share health information with their loved ones, 
and information that already is translated and accessible is 
more likely to be shared.  Using an existing curriculum has 
ensured speakers have a consistent and comprehensive 
resource for background information, which has increased the 
likelihood that accurate and appropriate information is shared 
with target audiences. Utilizing relationships with health care 
providers allows the speaker panel members to identify areas 
of high need throughout the state and facilitate appropriate 
connections for professional education and outreach.
Outcomes
Georgia anticipates 15 to 20 people will complete the training 
for the speaker panel in the spring of 2012. Panelists will 
track the number of speaking engagements, their audiences, 
and additional resources needed, and identify opportunities 
for additional panel presentations. Audiences will be given 
evaluation forms after participating in the panel discussions, 
to comment on the panel as an additional means of ongoing 
quality improvement.
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Lessons learned
The process of developing the speaker panel has revealed that 
SCD clients and their families are cautious of research, just 
for the sake of research. Information from the RuSH project 
must be relevant to the needs of clients, and offer a more 
immediate response to their participation. Identifying speakers 
who understand those needs and can deliver messages that 
articulate the importance of improving outcomes for clients is 
critical to supporting RuSH and supporting clients.
Building and maintaining relationships with clients and those 
who serve clients through support groups and health care is 
essential to reaching those most in need. Translating materials 
from one language to another is not sufficient; there has to be 
a culturally relevant connection. Materials that creatively use 
elements of Latino culture to create stories and characters for 
explaining the information have been well received.
Next Steps
Moving forward, the speaker panel trainings will be held in 
March 2012. Creation of an evaluation form will assist in tracking 
the effects of the panel on audiences. Presentation posters 
will be designed and printed as visual aids, with detailed 
information and data for each target area.
Contact Information
Sharon C. Quary, MS 
Georgia Department of Public Health 
E-mail: scquary@dhr.state.ga.us  
(404) 657-4143
Words from the Field
“The majority of my population doesn’t know what 
their hemoglobin is or why it’s important to take the 
test. We educate them about sickle cell after they 
know about hemoglobin.” 
— Janeth Spurlin
“Ten years from now, I don’t want to be doing the 
same thing. We need to make real improvement for 
people with sickle cell disease through education, 
legislation, and economic resources.” 
— Jackie George, 
Sickle Cell Foundation of Georgia
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Measuring Michigan’s Health:  
A Hemoglobinopathy Health Status Assessment
Program Overview
Newborn screening (NBS) for sickle cell disease (SCD) has 
been conducted at the Michigan Department of Community 
Health since 1987. Longitudinal follow-up of SCD case patients 
diagnosed by NBS traditionally has been carried out through 
5 years of age by NBS follow-up staff in collaboration with the 
Sickle Cell Disease Association of America, Michigan Chapter 
(SCDAA-MI). SCDAA-MI is a community-based organization 
whose contract is funded through Michigan’s NBS fee to 
provide medical management and support to families of 
children in Michigan with SCD. As part of the RuSH project, the 
Michigan Hemoglobinopathy Surveillance Quality Improvement 
Program (MiHemSQIP) expanded hemoglobinopathy follow-
up throughout the lifespan by enhanced monitoring of 
comorbidities, service use, and patient outcomes.
Michigan developed a health status assessment (HSA) 
to measure access to care, disease complications, health 
care use, financial status, and educational status among 
people in Michigan with SCD. The HSA provides annual 
self-reported information on patients, in order to learn more 
about Michigan’s population with SCD, provides feedback 
on educational initiatives provided by the SCDAA-MI, and 
facilitates conversation among patients and their families about 
important health issues related to SCD. 
Patient advocates employed by the SCDAA-MI work with 
families from the main office in Detroit, as well as four regional 
offices throughout Michigan, to ensure that all children with 
SCD are receiving proper care and services. Beginning in 2011, 
patient advocates included the HSA as part of their follow-
up protocol for families of children with SCD. Currently, the 
assessment is used as a surveillance tool for case patients of all 
ages. Parents answer the questions by telephone or in person; 
patients respond for themselves if they are 18 years of age or 
older. Patients with SCD not detected by NBS since 1987, adult 
SCD patients, and those born outside of Michigan are often 
identified through clinic referral or word of mouth, and may be 
included in the HSA.
Resources Needed
Michigan’s HSA questionnaire was adapted from the individual 
utilization questionnaire created by the Sickle Cell Disease 
Treatment Demonstration Program, and modified over time 
to specifically meet the needs of the state. Development and 
Implementation of the HSA would not have been possible 
without the SCDAA-MI or the Michigan Hemoglobinopathy 
Quality Improvement Committee (MiHemQIC). 
The MiHemQIC provided critical insight in the development of 
the HSA, and continues to provide feedback on a regular basis.
Benefits
The HSA has been included as part of regular follow-up for all 
SCD case patients detected via newborn screening since March 
2011 in an electronic, Web-based application via the Michigan 
Care Improvement Registry (MCIR). The hemoglobinopathy 
module of MCIR allows patients to be managed efficiently 
by SCDAA-MI staff and NBS follow-up staff, and could be 
expanded to include clinicians. The electronic HSA application 
was later launched within the MCIR module for all children 1 
through 5 years of age initially detected by NBS, and has been 
expanded to include older children and adults, such as those 
who are not detected through NBS. This computerized form for 
self-reported or clinically verified health information allows for 
real-time data extraction and quality improvement. Aggregate 
results are available immediately to SCDAA-MI patient 
advocates and staff, providing valuable feedback for provision 
of services. Developing the MCIR module and HSA through 
RuSH has allowed for ongoing validation and evaluation of the 
assessment, with potential for significant quality improvement 
as the HSA is expanded to include a larger population.
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Outcomes
During the first 6 months of implementation, 135 assessments 
were completed by patient advocates across the state.  
As each HSA is conducted, important conversations often  
occur between parents of children with SCD and SCDAA-
MI follow-up staff on topics that might not have come up 
otherwise: vision screening, hydroxyurea therapy, nutritional 
supplements, and bone marrow transplants. Conversations 
about these issues come up naturally, allowing for an 
impromptu educational session during the data collection 
process for participating families.
Lessons Learned
The questionnaire is modified and adapted continually for 
quality improvement by MiHemSQIP staff as more HSAs are 
conducted. All involved patient advocates have agreed on 
and use the same questionnaire. Original plans for annual 
assessments were not feasible, and the MiHemSQIP currently  
is modifying the assessment to be conducted once every 2 
years, with the first HSA being conducted with parents, in-
person or by telephone when children identified by NBS are  
12 months of age.
Next Steps
As Michigan continues to improve the MCIR sickle cell 
application, there is hope of building integrated report-making 
tools that will provide aggregate and individual-level data to 
SCDAA-MI staff.
Contact Info
William Young, PhD 
Michigan Department of Community Health 
E-mail: youngw@michigan.gov 
Phone: 517-335-8938 
MiHemSQIP Website: www.michigan.gov/rush 
Words from the Field
“Our families are excited to hear about the RuSH 
program and eager to “stand up and be counted”. 
We have found that the health status assessment 
frequently has the added value of initiating an 
impromptu mini education session on hydroxyurea, 
bone marrow transplant, transfusions, vitamin 
supplements . . . the list goes on and on.” 
— Wanda Whitten-Shurney, 
Executive Director, Sickle Cell Disease Association of America, 
Michigan Chapter
“Michigan’s hematologists have been actively involved 
with every step of HSA development as part of their 
advisory group duties. Often, their response to content 
during meetings has led to vibrant conversations on 
specific treatment experiences related to sickle cell 
disease, inadvertently improving quality of care and 
best practices for hematology throughout our state.” 
— Robin O’Neill, 
Michigan Hemoglobinopathy Surveillance & Quality 
Improvement Coordinator
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Garnering State-wide Support for RuSH: 
Regional Provider Meetings in New York
Program Overview 
The New York RuSH project team launched a community 
outreach program in summer 2011 to achieve one of the 
project’s objectives: to identify at-risk populations with 
hemoglobinopathies in New York State (NYS). This program, 
a collaboration of the RuSH project team, the RuSH advisory 
committee, and a community-based organization—the 
Cooley’s Anemia Foundation—focused on (1) outreach via 
regional meetings to community-based health care providers 
across the state who specialize in hemoglobinopathies and (2) 
administration among providers of  a survey with questions 
about characteristics of hemoglobinopathy specialty care 
centers (HgbSCCs) and the degree of clinical information 
available regarding affected patients, including confirmatory 
diagnoses, comorbidities, and health care use. 
Resources Needed
A survey was developed to assess the long-term health care 
status of people with hemoglobinopathies, identify clinical 
information collected at HgbSCCs, and explore the possibility of 
sharing and accessing collected clinical data. The brief survey, 
which consisted of 16 close-ended questions, was filled out by 
the participating health care providers at the regional meetings. 
It also was sent via e-mail to providers who did not attend the 
regional meetings. Project staff planned and conducted the 
regional meetings and developed and administered the survey. 
The cost of these activities included staff preparation time, 
travel, follow-up meetings with registrants and participants, 
meeting spaces, equipment rentals, handouts, materials, and 
the annual service charge for the online survey tool.
Benefits
The most notable benefits of the regional meetings were: 
 y Enhanced collaboration among the project team members, 
advisory committee members and community-based 
organizations.
 y Opportunities for in-person interaction and relationship 
building between the project staff, community, and 
providers.
 y Demonstration of the feasibility of obtaining clinical data 
from the HgbSCCs for RuSH.
Outcomes
A database containing 258 providers representing 63 HgbSCCs 
across NYS was constructed. All providers were contacted 
and invited to the New York RuSH regional meetings. In fall 
2011, two regional meetings were conducted in the New 
York City area; three providers representing three HgbSCCs 
and six providers representing five HgbSCCs participated in 
the meetings in Brooklyn and Manhattan, respectively. Only 
five providers registered for the meetings in the upstate New 
York area (three in Albany and two in Syracuse). Due to low 
registration in this area, registrants were invited to attend a 
meeting in Herkimer, New York, which is located geographically 
between Albany and Syracuse. Unfortunately, the meeting was 
canceled due to travel complications following the devastation 
caused by Hurricanes Irene and Lee. 
After the regional meetings, an email containing a brief 
introduction to the survey, the Centers for Disease Control 
and Prevention’s RuSH project fact sheet, and an executive 
summary about the New York RuSH project, along with a 
Web link to the online survey, was sent to the 249 providers 
representing 55 HgbSCCs who did not attend a regional 
meeting. Two follow-up emails were sent to non-responders in 
2-week intervals as a reminder to complete the online survey. 
Reminder calls also were made to complete the survey through 
a telephone interview. To date, 90 providers representing 
49 HgbSCCs have completed the survey, resulting in a 78% 
response rate (49/63 HgbSCCs). Implementation of the regional 
meetings has helped achieve the main objectives of the 
project’s outreach efforts, as well as jumpstarted fulfillment of 
the overall RuSH program objective.
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Lessons Learned
Project staff must work closely with clinicians and staff at the 
HgbSCCs to facilitate the Institutional Review Board application 
and approval process for collecting and sharing clinical data. 
The process of providing all necessary documents, guidance, 
and assistance is labor intensive. Preparing a thorough list 
of essential data elements and conducting active follow-up 
to obtain timely progress updates are critical to successful 
outreach efforts with community-based HgbSCCs and 
providers across NYS.
Next Steps
The New York RuSH project team will continue outreach efforts 
with community-based HgbSCCs and clinicians who provide 
care to hemoglobinopathy patients across NYS. In-person 
regional meetings in downstate (excluding New York City) 
and upstate New York areas will be planned and conducted. 
Ad hoc webinars or teleconferences on topics of interest to 
collaborative participants will be organized. Project staff plan to 
analyze survey results and prepare a summary report to share 
with the HgbSCCs and the RuSH project collaborators.
Contact Information
Ying Wang, PhD, MPH 
New York State Department of Health 
wxy01@health.state.ny.us 
(518) 402-7716 
NY RuSH website: http://www.wadsworth.org/newborn/RuSH/
rush_overview.html 
Words from the Field 
“Collaboration: Key to Success for RuSH! - Case 
ascertainment from multiple sources/programs with 
collaborative efforts is a crucial step to establish a 
population-based registry and surveillance system for 
hemoglobinopathies.” 
— New York RuSH Project Team
“Community outreach provides opportunities for in-
person interaction and relationship-building between 
the project staff and health care providers for effective 
collaboration on RuSH project.” 
— Dr. Ying Wang, 
New York State Department of Health
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Faith-based Initiative:  
North Carolina’s Approach to Community Outreach 
for Hemoglobinopathies
Overview
The initial collaborators  in North Carolina‘s RuSH program 
included community-based organizations and medical centers 
with expertise in sickle cell disease(SCD)  and thalassemia, 
along with the Governor’s Council on Sickle Cell Disease and 
other Related Disorders. As the program progressed, the 
North Carolina Community Partnerships and Health Education 
Workgroup formalized and developed a plan to increase 
awareness and education related to SCD and thalassemia in 
North Carolina through a faith-based initiative.
The North Carolina Faith-based Initiative (NCFI) was established 
in 2011 to enhance educational and outreach strategies 
involving key faith-based communities. The goal of the 
initiative is to build a systematic approach for including faith-
based organizations in hemoglobinopathy awareness and 
education activities by:
 y Partnering with governing bodies of faith-based institutions 
of all sizes.
 y Working with the medical community for technical 
assistance and support.
 y Enhancing faith-based partnerships through alliances with 
community-based organizations and regional educator 
counselors.
 y Utilizing the Cooley’s Anemia Foundation for thalassemia 
expertise and education materials.
Resources Needed
This project began by formalizing partnerships with statewide 
faith-based organizations to garner participation and support. 
Initial collaborations included the General Baptist State 
Convention of North Carolina’s Center for Health and Healing 
and the North Carolina Greek Orthodox Archdiocese, because 
of high SCD and thalassemia prevalence rates among Black or 
African-American and Greek populations, respectively.  
The General Baptist State Convention of North Carolina 
represents over 1,700 Black or African-American congregations, 
and there are 13 Greek Orthodox Churches in North Carolina,  
all strategically located in major cities with large  
Greek communities. 
An educational toolkit was developed, with input from various 
faith leaders, containing a program overview, brochures, church 
fans, bulletin inserts, and a DVD. A Microsoft® PowerPoint 
presentation for faith-based audiences also was developed and 
delivered by a representative of the program (i.e., sickle cell 
educator counselors, community-based organization members, 
or medical center staff). The state program’s education 
consultant provided programmatic oversight.
Ample staff time and leadership are required to facilitate 
partnerships with faith-based organizations to develop the 
best educational approach for each organization. Partnership 
meetings were held to plan, coordinate, and schedule activities 
with key stakeholders. Staff trainings were used to develop 
critical messages, ensuring consistent delivery. Training 
expenses were attributed to staff time, travel, and conducting 
follow-up sessions to strengthen future programs. A toolkit of 
materials, general travel expenses, website postings, equipment 
and supplies should be considered. A significant cost savings 
was achieved through a partnership with the Cooley’s Anemia 
Foundation, which provided technical assistance, educational 
materials, and training about thalassemia at no cost. 
Benefits 
The NCFI provides a consistent outreach message to faith-
based organizations. SCD and thalassemia education is  
included in church health programs and provides a platform 
for a public health message. This initiative also provides an 
opportunity to identify new clients (individuals living with 
SCD or thalassemia) and those who have been lost to follow-
up. The faith-based initiative creates a support system for 
individuals with SCD and thalassemia and is a cost-effective 
method to increase awareness and education through ongoing 
partnerships and networking. 
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Outcomes
Preliminary data have indicated that faith-based communities 
are receptive to this approach. Information gained from 
the participant evaluation tool was favorable, with 90% of 
participants demonstrating an increased knowledge of SCD 
and thalassemia after attending the session. 
Lessons Learned
It is important to provide culturally appropriate and 
personalized information based on religious practices. 
Identifying an advocate in the faith-based setting, such as a 
gatekeeper or pastor, as a point of contact for the program 
is key for effective communication. Connecting with 
parishioners who are affected by SCD or thalassemia can be 
a way to personalize the connection with the congregation. 
Sustainability of the program is an important discussion to have 
with key leaders, so efforts do not dissolve with time or change 
of leadership. 
Next Steps
The NCFI includes plans to expand activities to other 
traditional, nontraditional, and nondenominational faith-
based organizations. NCFI activities will be evaluated through 
surveys and focus groups, evaluations, and key informant 
interviews. The program will examine how this project 
aligns with the White House Office of Faith-based and 
Neighborhood Partnerships to determine future opportunities 
for enhancement and expansion of awareness and education of 
hemoglobinopathies.
Contact Information
Belinda D. Pettiford, MPH 
North Carolina Department of Health and Human Services 
Belinda.pettiford@dhhs.nc.gov 
919-707-5699 
NC RuSH Website: www.ncsicklecellprogram.org
Words from the Field
“We want to empower people with knowledge. 
We want to give information that will allow good 
decision- making. We want to empower people to take 
charge of their lives. The information that you provide 
allows us to give that hand up to a healthier life.” 
— Rev. Warren 
of Little Rock AME Zion Church, 
Charlotte, NC
“This type of outreach connects with one’s soul, and 
creates long-lasting relationships; and our efforts 
prove that.” 
— Aziz Coleman, 
Sickle Cell Educator Counselor, Community Health Interventions 
and Sickle Cell Agency
“The presentation to our women’s group on 
thalassemia was very educational. It answered 
questions that people thought that they had the 
answers to but were wrong. Now they are giving the 
right information to their daughters, nieces, and 
other relatives.” 
— Ann-Marie Dentiste, 
Chapter President, Ladies Philoptochos Society, Annunciation 
Greek Orthodox Church, 
Winston-Salem, NC
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Answering the Call:  
Pennsylvania’s Toll-free Phone Number for 
Hemoglobinopathy Health Care Referrals 
Program Overview
One of Pennsylvania’s goals is to provide a mechanism to 
directly reach individuals with a hemoglobinopathy diagnosis. 
The unique partnership between the Pennsylvania RuSH 
Team, hospitals, and community-based organizations has 
resulted in a collaboration to establish a toll-free number 
(1-855-4SICKLE) that allows individuals with sickle cell disease 
(SCD) or thalassemia to connect with regional community-
based programs and comprehensive hemoglobinopathy 
programs, and enroll in appropriate care, as well as the state 
hemoglobinopathies database.
Following a greeting and brief explanation of the purpose 
of the toll-free number, callers will be prompted to use their 
touch-tone key pad to indicate whether they have SCD or 
thalassemia and to enter their ZIP Code. Calls will be routed 
to the community-based organization (CBO) that is best 
prepared to service the ZIP Code indicated. CBOs will use a 
script and intake form that includes questions to ascertain 
contact and demographic information; diagnosis and current 
source of medical care and insurance; and how the caller heard 
about the toll-free number. The contacted organization also 
will coordinate referral appointment scheduling and, when 
necessary, provide someone to accompany the individual to the 
appointment. 
Callers after business hours will be prompted to leave a call 
back number, which will be retrieved and returned on the 
next business day. Aggregate descriptive data of the toll-free 
number use will be obtained and each organization will report 
to the Pennsylvania Department of Health with information 
obtained through the call script and intake form and the 
outcome of health care referrals.
Resources Needed
Flyers, posters, and radio advertisements have been developed 
to advertise the toll-free number. Marketing has been targeted 
to media outlets most popular among key ethnic groups, as 
well as frequently accessed locations such as supermarkets, 
churches, schools, modes of public transportation, and area 
health care provider sites. The primary resources needed are a 
vendor to provide telephone service and partnerships between 
community-based organizations across the state and the state 
health department. Various personnel with the necessary 
credentials and appropriate training are needed to answer the 
calls, complete the script and intake forms, make referrals, and 
follow up on the callers’ care. The cost of this program depends 
heavily on the telephone service used, the number of staff with 
the required credentials, advertisement of the toll-free number, 
and any modifications to data systems to provide required 
reporting. 
Benefits
The primary benefit of the proposed toll-free number will be its 
ability to provide a direct connection between individuals with 
hemoglobinopathies and comprehensive care.  This program 
also will give those individuals an opportunity to be included 
in state prevalence estimates, as well as generate high-quality 
individual-level surveillance data. Pennsylvania anticipates 
the data will be informative regarding demographics, barriers 
to care, and the ability to conduct Geographic Information 
System (GIS) mapping for populations of individuals with 
hemoglobinopathies to provide effective and continuous care.
Outcomes
The anticipated outcomes are:
 y  More accurate and reliable information on the number of 
individuals and families living with SCD and thalassemia.
 y Improved knowledge and awareness about SCD and 
thalassemia. 
 y Increased access to health care, education, treatment, and 
supportive services to individuals and families affected by 
SCD and thalassemia.
By connecting patients with comprehensive care centers, the 
information obtained by the state will be more reliable for 
predictions for state resource needs and allocations.
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Lessons Learned
Appropriations should be made to anticipate delays in program 
implementation, such as working with the telephone service 
provider and coordinating the logistics of connecting each 
caller with the necessary service and follow-up. A thorough 
and organized process is needed to facilitate a clear and 
comprehensive plan for disseminating information about the 
toll-free line to consumers, making sure all health care providers 
are on board with the procedures and the technical aspects of 
the toll-free line are working properly.
Next Steps
An assessment of the first month’s activities for the toll-free 
line will be incorporated into ongoing operations and training. 
Pennsylvania anticipates initial data and feedback on the toll-
free telephone number use in March 2012. The toll-free number 
has been proposed as an ongoing activity for Pennsylvania’s 
comprehensive hemoglobinopathy programs beyond the life 
of the RuSH grant. The toll-free number concept was chosen 
because of the ease of access for individuals participating in 
surveillance and any future registries, and because it is a model 
that may be replicable from a statewide to a national effort.
Contact Information
William Cramer, M.Ed. 
Pennsylvania Department of Health 
wcramer@pa.gov 
(717) 783-8143
Words from the Field  
“As many think of sickle cell as the forgotten disease, 
the RuSH Program dispels that notion. Call the toll-
free number and be informed.” 
— Stanley Simpkins, 
Executive Director, Sickle Cell Disease Association of America, 
Philadelphia/Delaware Valley Chapter
“If you have sickle cell disease or thalassemia . . 
. we’re here and WE CARE!  Call 1-855-4SICKLE 
TODAY! Through the creation of this 1-855-4SICKLE 
line, we are committing ourselves to be a resource for 
all persons with sickle cell disease and thalassemia. 
It is our intent to be consistent and effective in 
connecting persons to the resources that they need. 
Whether that means answering a question for a 
person who has been in comprehensive care for some 
time, or for connecting newly identified persons to 
comprehensive care for the first time, we’re here and 
we care!” 
— Andrea Williams, 
Executive Director, Children’s Sickle Cell Foundation, Inc.
“Why should surveillance reach out to patients with 
hemoglobinopathies? Because they may not have 
access to quality care and may be suffering from 
disease- related complications.” 
— Dr. Lakshmanan Krishnamurti, 
Director of Sickle Cell Program, Children’s Hospital of Pittsburgh
26
RuSH—Strategies from the Field: Health Promotion
Acknowledgments
The Centers for Disease Control and Prevention, National Center 
on Birth Defects and Developmental Disabilities, Division of 
Blood Disorders thanks all state and federal personnel involved 
with the State-based Surveillance for Hemoglobinopathies 
Cooperative Agreements DD09-909 and DD10-1017, in 
particular members of the RuSH Community Engagement 
and Health Education Workgroup, funded by the National 
Heart Lung and Blood Institute/National Institutes of Health, in 
addition to associated steering and advisory groups for their 
contributions to the production of this document. 
Gratitude is extended to the dedicated clinicians, health 
care providers, and community-based organizations that 
support individuals and countless families affected by 
hemoglobinopathies. Finally, every sickle cell disease and 
thalassemia client is appreciated for his or her participation in 
research and surveillance efforts that will change the course of 
health care and health policy for future generations.
27
Registry and Surveillance System for Hemoglobinopathies
The following agencies and organizations also are acknowledged as key contributors to the  
activities summarized in this publication:
Children’s Healthcare of Atlanta 
www.choa.org
Children’s Hospital of Philadelphia 
www.chop.edu
Children’s Hospital of Pittsburgh 
www.chp.edu
Children’s Sickle Cell Foundation, Inc. 
http://cscfkids.org/ 
Community Health Interventions and Sickle Cell Agency 
www.communityhealthinterventions.org 
Cooley’s Anemia Foundation 
www.cooleysanemia.org
Cooley’s Anemia Foundation 
www.cooleysanemia.org
Georgia Health Policy Center 
www.gsu.edu/ghpc
Georgia Health Sciences University 
www.georgiahealth.edu/
Grady Health System 
www.gradyhealth.org 
Memorial Healthcare System: Sickle Cell Day Hospital 
www.floridasickle.org
NC Sickle Cell Syndrome Program 
http://www.ncsicklecellprogram.org/
New York State Department of Health, Congenital 
Malformations Registry 
http://www.health.ny.gov/diseases/congenital_malformations/
cmrhome.htm 
New York State Department of Health, Newborn Screening 
Program 
www.wadsworth.org/newborn/index.html
North Carolina Governor’s Council on Sickle Cell Disease and 
Related Disorders
Pennsylvania Oncology Hematology Associates 
http://pennoncology.com
Piedmont Health Services and Sickle Cell Agency 
www.piedmonthealthservices.org 
Shenango Valley Urban League 
www.svuleague.org
Sickle Cell Disease Association of America, Inc. Eastern North 
Carolina Chapter 
www.sicklecelleasternnc.org 
Sickle Cell Disease Association of America, Inc. 
http://www.sicklecelldisease.org
Sickle Cell Disease Association of America, Philadelphia/
Delaware Valley Chapter 
www.sicklecelldisorder.com
Sickle Cell Disease Association of Florida 
http://scdaflorida.com/
Sickle Cell Foundation of Georgia, Inc. 
http://www.sicklecellga.org
Sickle Cell Society, Inc. - Pittsburgh 
www.sicklecellsocietypgh.org 
South Central Pennsylvania Sickle Cell Council 
http://scpascc.org/
United Neighborhood Facilities Health Care Corp 
http://thejfkcenter.org/UNFHCC
University of South Florida 
www.usf.edu
Zoe Consulting, Santa Monica, CA 
28
RuSH—Strategies from the Field: Health Promotion
Notes:
29
Registry and Surveillance System for Hemoglobinopathies
Notes:
30
RuSH—Strategies from the Field: Health Promotion
Notes:

For more information contact:
Centers for Disease Control and Prevention
National Center on Birth Defects and Developmental Disabilities
Division of Blood Disorders
1600 Clifton Road MS E-87
Atlanta, GA 30333
800-CDC-INFO (800-232-4636) 
TTY: (888) 232-6348
24 Hours/Every Day
cdcinfo@cdc.gov 
National Center on Birth Defects and Developmental Disabilities
Division of Blood Disorders
